XML 17 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Expenses    
Research and development $ 11,606,197 $ 8,449,267
General and administrative 4,705,674 4,294,545
Total expenses 16,311,871 12,743,812
Loss from operations (16,311,871) (12,743,812)
Foreign exchange losses (6,313) (18,109)
Investment income 490,984 414,307
Interest expense   (70,649)
Net loss $ (15,827,200) $ (12,418,263)
Net loss per share, basic and diluted $ (0.41) $ (0.32)
Weighted average shares outstanding, basic and diluted 38,968,110 38,749,343